Fundz

Nomax Therapeutics reported raising $1.16 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATENov 10, 2025Late filing, first sale Oct 18, 2021$1.2M of $10M raised

Amount Raised

$1.16 Million

$1.16 Million sold, per SEC Form D (first sale Oct 18, 2021)

Round Type

Venture

MiamiBiotechnologyresearch

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Metallomix that raised within 45 days of this round, from Fundz verified event records.

  • Northwest Biotherapeutics raised $15M (Funding Round) on November 29, 2021.
  • Dualitas Therapeutics raised $30M on October 7, 2021.
  • Nusano raised $48M on September 23, 2021.
  • Cambrian BioPharma raised $92M on December 2, 2021.
  • Avivomed raised $32M (Series A) on December 2, 2021.
  • Amarna Therapeutics raised $5.4M (Funding Round) on December 1, 2021.

Who to call at Metallomix, and when

A new round usually means Metallomix is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Metallomix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Metallomix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Metallomix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Metallomix

Location

175 SW 7th St

Miami, Florida, United States

About

Metallomix, Inc. was formerly known as Nomax Therapeutics, Inc. Metallomix is a pioneering biotech company dedicated to developing truly novel medicines by studying isotopic fractionation in cells and tissues and creating safe, effective isotope-selective modulators that target scientifically validated pathways. Focusing on the roles of metals and isotopic fractions in human physiology, particularly in inflammation and oxidative stress, Metallomix seeks to restore the balance between cellular homeostasis and the body’s inflammatory and oxidative responses. By precisely modulating cellular processes with non-radioactive isotopes, the company aims to deliver safer and more effective treatments for oncological and age-related diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Metallomix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSergey G., EVP & Interim CFOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Metallomix's next move

See what Strategic adds

Metallomix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.